Telavic combined with Urso

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Vomiting Hospitalization 4/10/2012 64 Male 152 lb 1/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Pancytopenia Other Serious 4/16/2012 64 Female 117 lb 2/13/2013 Consumer Jp
Primary
Secondary
Concomitant
Pancreatitis Acute Hospitalization 4/16/2012 58 Male 146 lb 3/4/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Failure Acute Hospitalization 6/8/2012 69 Female 121 lb 6/17/2013 Consumer Jp
Primary
Secondary
Concomitant
Sepsis Hospitalization 4/10/2012 67 Male 154 lb 4/16/2013 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Other Serious 4/23/2012 66 Female 110 lb 6/24/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Other Serious 4/25/2012 56 Male 146 lb 3/13/2013 Physician Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 2/7/2012 51 Male 157 lb 1/15/2013 Physician Jp
Primary
Secondary
Concomitant
Rash Hospitalization 6/18/2012 9/4/2012 Physician Jp
Primary
Secondary
Concomitant
Therapeutic Response Decreased Hospitalization 4/12/2012 60 Female 130 lb 11/23/2012 Consumer Jp
Primary
Secondary
Concomitant
Rash Other Serious 6/6/2012 52 Male 154 lb 6/17/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 5/11/2012 53 Male 165 lb 3/5/2013 Consumer Jp
Primary
Secondary
Concomitant
Syncope Life Threatening 6/30/2012 59 Male 190 lb 4/25/2013 Consumer Jp
Primary
Secondary
Concomitant
Neutropenia Other Serious 5/19/2012 9/11/2012 Consumer Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Hospitalization 5/29/2012 57 Female 110 lb 12/13/2012 Jp
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 2/2/2012 65 Male 157 lb 5/21/2013 Consumer Jp
Primary
Secondary
Concomitant
Pleural Effusion Hospitalization 5/14/2012 67 Male 159 lb 10/4/2012 Physician Jp
Primary
Secondary
Concomitant
Renal Failure Acute Other Serious 6/24/2012 66 Male 139 lb 5/17/2013 Consumer Jp
Primary
Secondary
Concomitant
Platelet Count Decreased Other Serious 3/16/2012 69 Male 194 lb 3/11/2013 Consumer Jp
Primary
Secondary
Concomitant
Blood Creatinine Increased Hospitalization 4/13/2012 74 Female 143 lb 11/14/2012 Consumer Jp
Primary
Secondary
Concomitant
Pulmonary Embolism Hospitalization 7/19/2012 66 Female 159 lb 6/6/2013 Consumer Jp
Primary
Secondary
Concomitant
Vomiting Hospitalization 6/2/2012 55 Male 108 lb 3/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Platelet Count Decreased Other Serious 3/12/2012 64 Female 141 lb 2/4/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 6/2/2012 68 Female 130 lb 12/21/2012 Consumer Jp
Primary
Secondary
Concomitant
Urinary Bladder Haemorrhage Other Serious 5/16/2012 63 Female 150 lb 3/13/2013 Pharmacist Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 6/22/2012 67 Male 126 lb 3/25/2013 Consumer Jp
Primary
Secondary
Concomitant
Hypercreatininaemia Other Serious 6/21/2012 59 Female 101 lb 11/27/2012 Consumer Jp
Primary
Secondary
Concomitant
Skin Lesion Other Serious 5/2/2012 59 Male 143 lb 2/8/2013 Consumer Jp
Primary
Secondary
Concomitant
Femoral Neck Fracture Hospitalization 7/14/2012 9/17/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 1/31/2012 77 Female 137 lb 12/5/2012 Consumer Jp
Primary
Secondary
Concomitant
Prostatitis Hospitalization 5/7/2012 59 Male 137 lb 3/18/2013 Consumer Jp
Primary
Secondary
Concomitant
Interstitial Lung Disease Other Serious 2/24/2012 61 Male 141 lb 12/11/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 4/27/2012 77 Female 108 lb 12/7/2012 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 1/27/2012 65 Female 137 lb 12/10/2012 Consumer Jp
Primary
Secondary
Concomitant
Depressive Symptom Other Serious 6/30/2012 46 Male 152 lb 3/5/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 6/1/2012 60 Male 187 lb 10/4/2012 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Hospitalization 4/29/2012 66 Male 130 lb 2/12/2013 Consumer Jp
Primary
Secondary
Concomitant
Platelet Count Decreased 4/18/2012 56 Male 150 lb 2/24/2013 Consumer Jp
Primary
Secondary
Concomitant
Erythema Multiforme Hospitalization 4/27/2012 65 Male 139 lb 12/22/2012 Consumer Jp
Primary
Secondary
Concomitant
Malaise Hospitalization 3/17/2012 8/30/2012 Consumer Jp
Primary
Secondary
Concomitant
Hyperuricaemia 3/23/2012 47 Male 146 lb 2/1/2013 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 4/22/2012 58 Male 121 lb 12/21/2012 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased 5/2/2012 12/31/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 7/17/2012 53 Male 161 lb 10/3/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 2/10/2012 8/31/2012 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 2/7/2012 51 Male 157 lb 1/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Failure Other Serious 2/12/2012 63 Male 99 lb 10/17/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 3/19/2012 51 Male 168 lb 1/17/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 3/6/2012 71 Male 123 lb 2/11/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 5/8/2012 9/4/2012 Consumer Country Not Specified
Primary
Secondary
Concomitant
Nausea Hospitalization 2/16/2012 54 Female 123 lb 11/29/2012 Consumer Jp
Primary
Secondary
Concomitant
Rash Pruritic Hospitalization 3/26/2012 9/6/2012 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 5/9/2012 64 Male 132 lb 2/21/2013 Consumer Jp
Primary
Secondary
Concomitant
Psychiatric Symptom Hospitalization 4/11/2012 70 Female 115 lb 2/4/2013 Consumer Jp
Primary
Secondary
Concomitant
Drug Eruption Other Serious 2/28/2012 71 Male 130 lb 1/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Rhabdomyolysis Other Serious 2/28/2012 49 Male 152 lb 12/5/2012 Consumer Jp
Primary
Secondary
Concomitant
Neutrophil Count Decreased Hospitalization 2/17/2012 67 Female 110 lb 2/27/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 5/8/2012 65 Female 123 lb 2/12/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 5/9/2012 59 Male 150 lb 1/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Pancytopenia Other Serious 2012 9/6/2012 Consumer Jp
Primary
Secondary
Concomitant
Neutropenia Other Serious 7/17/2012 68 Female 137 lb 11/22/2012 Consumer Jp
Primary
Secondary
Concomitant
Anaemia Hospitalization 6/20/2012 41 Male 150 lb 2/14/2013 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 6/8/2012 71 Female 121 lb 12/26/2012 Consumer Jp
Primary
Secondary
Concomitant
Rash Other Serious 6/11/2012 64 Male 146 lb 1/8/2013 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 3/6/2012 62 Male 119 lb 11/8/2012 Consumer Jp
Primary
Secondary
Concomitant
Pneumonia Aspiration Other Serious 4/23/2012 70 Female 115 lb 2/25/2013 Consumer Jp
Primary
Secondary
Concomitant
Thrombocytopenia Other Serious 1/12/2012 9/11/2012 Consumer Jp
Primary
Secondary
Concomitant
Rash Hospitalization 7/28/2012 51 Female 117 lb 3/28/2013 Consumer Jp
Primary
Secondary
Concomitant
Blood Creatinine Increased Hospitalization 7/2/2012 64 Female 128 lb 3/5/2013 Consumer Jp
Primary
Secondary
Concomitant
Sepsis Other Serious 3/13/2012 70 Male 165 lb 2/18/2013 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 3/16/2012 62 Male 157 lb 2/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Other Serious 3/26/2012 60 Female 130 lb 2/25/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Other Serious 3/7/2012 62 Male 150 lb 2/7/2013 Consumer Jp
Primary
Secondary
Concomitant
Retinal Haemorrhage 5/2/2012 45 Male 170 lb 2/7/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 3/22/2012 9/17/2012 Consumer Jp
Primary
Secondary
Concomitant
Hyperuricaemia 5/18/2012 69 Male 139 lb 2/20/2013 Consumer Jp
Primary
Secondary
Concomitant
Retinopathy 7/17/2012 NotSpecified 1/17/2013 Consumer Jp
Primary
Secondary
Concomitant
Pyrexia 5/10/2012 25 Male 121 lb 2/14/2013 Consumer Jp
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/2012 65 Female 106 lb 3/14/2013 Consumer Jp
Primary
Secondary
Concomitant
Psychiatric Symptom Hospitalization 6/1/2012 9/19/2012 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Other Serious 4/4/2012 64 Female 119 lb 2/1/2013 Consumer Jp
Primary
Secondary
Concomitant
Eczema Asteatotic Hospitalization 7/24/2012 62 Female 121 lb 2/21/2013 Consumer Jp
Primary
Secondary
Concomitant
Drug Eruption Other Serious 7/20/2012 55 Male 183 lb 9/21/2012 Consumer Jp
Primary
Secondary
Concomitant
Pleural Effusion Hospitalization 5/14/2012 67 Male 159 lb 1/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Hyperuricaemia Other Serious 7/20/2012 63 Female 126 lb 11/6/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Failure Hospitalization 9/8/2012 66 Female 130 lb 2/18/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 2/25/2012 56 Male 143 lb 10/4/2012 Consumer Country Not Specified
Primary
Secondary
Concomitant
Hyperkalaemia Other Serious 7/21/2012 63 Male 139 lb 10/8/2012 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Hospitalization 8/12/2012 60 Female 121 lb 2/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Failure Hospitalization 8/9/2012 61 Male 128 lb 11/24/2012 Consumer Jp
Primary
Secondary
Concomitant
Gastritis Hospitalization 3/26/2012 66 Male 168 lb 10/12/2012 Consumer Jp
Primary
Secondary
Concomitant
Hyperuricaemia Other Serious 9/5/2012 55 Female 126 lb 12/12/2012 Consumer Jp
Primary
Secondary
Concomitant
Pancreatitis Other Serious 8/2012 61 Male 132 lb 1/30/2013 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Hospitalization 2/16/2012 60 Female 104 lb 2/19/2013 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Other Serious 4/17/2012 64 Female 95 lb 12/14/2012 Consumer Jp
Primary
Secondary
Concomitant
Optic Neuritis Other Serious 4/20/2012 51 Male 132 lb 3/4/2013 Consumer Jp
Primary
Secondary
Concomitant
Toxic Skin Eruption Hospitalization 3/25/2012 52 Male 141 lb 10/22/2012 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Other Serious 4/27/2012 69 Male 157 lb 11/29/2012 Consumer Jp
Primary
Secondary
Concomitant
Anaemia Hospitalization 9/20/2012 68 Male 163 lb 12/27/2012 Consumer Jp
Primary
Secondary
Concomitant
Drug Eruption Other Serious 8/18/2012 49 Male 163 lb 10/23/2012 Consumer Jp
Primary
Secondary
Concomitant
Anaemia Other Serious 4/25/2012 62 Female 86 lb 12/4/2012 Jp
Primary
Secondary
Concomitant
Renal Disorder Hospitalization 9/20/2012 69 Male 119 lb 12/23/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 8/16/2012 73 Male 106 lb 11/26/2012 Consumer Jp
Primary
Secondary
Concomitant
Vomiting Other Serious 9/8/2012 49 Male 157 lb 11/30/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 8/25/2012 64 Male 130 lb 11/2/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 2012 55 Female 108 lb 2/12/2013 Consumer Jp
Primary
Secondary
Concomitant
Haemoglobin Decreased Other Serious 4/11/2012 63 Female 110 lb 3/4/2013 Consumer Jp
Primary
Secondary
Concomitant
Skin Disorder Other Serious 5/9/2012 67 Female 128 lb 11/7/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Disorder Hospitalization 9/10/2012 66 Male 126 lb 1/11/2013 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 7/17/2012 68 Female 137 lb 1/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Hypokalaemia Other Serious 10/17/2012 57 Male 165 lb 3/15/2013 Consumer Jp
Primary
Secondary
Concomitant
Drug Eruption Other Serious 11/4/2012 61 Male 174 lb 12/31/2012 Consumer Jp
Primary
Secondary
Concomitant
Vomiting Other Serious 9/8/2012 51 Female 152 lb 11/20/2012 Consumer Country Not Specified
Primary
Secondary
Concomitant
Rash Other Serious 2/8/2012 60 Female 132 lb 11/23/2012 Consumer Jp
Primary
Secondary
Concomitant
Erythema Multiforme Hospitalization 9/11/2012 64 Male 132 lb 1/8/2013 Consumer Jp
Primary
Secondary
Concomitant
Hyperuricaemia Other Serious 3/12/2012 68 Male 130 lb 11/27/2012 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 3/27/2012 74 Male 132 lb 11/28/2012 Consumer Jp
Primary
Secondary
Concomitant
Rash Hospitalization 11/17/2012 60 Female 12/31/2012 Other Health Professional Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 3/13/2012 66 Male 121 lb 3/5/2013 Physician Jp
Primary
Secondary
Concomitant
Renal Disorder Other Serious 9/24/2012 79 Male 143 lb 11/29/2012 Consumer Jp
Primary
Secondary
Concomitant
Decreased Appetite Hospitalization 4/25/2012 60 Male 134 lb 12/4/2012 Consumer Country Not Specified
Primary
Secondary
Concomitant
Renal Impairment Hospitalization 11/12/2012 65 Male 148 lb 2/12/2013 Consumer Jp
Primary
Secondary
Concomitant
Liver Disorder Other Serious 4/17/2012 68 Male 183 lb 12/7/2012 Consumer Jp
Primary
Secondary
Concomitant
White Blood Cell Count Decreased 11/9/2012 72 Female 115 lb 1/13/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Hospitalization 11/17/2012 60 Female 123 lb 1/16/2013 Consumer Jp
Primary
Secondary
Concomitant
Platelet Count Decreased Other Serious 4/13/2012 51 Female 141 lb 2/18/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Tubular Necrosis Hospitalization 1/23/2012 69 Female 104 lb 12/3/2012 Consumer Jp
Primary
Secondary
Concomitant
Erythema Hospitalization 11/10/2012 66 Male 157 lb 1/16/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Hospitalization 11/6/2012 68 Male 3/25/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Urinary Tract Infection Hospitalization 5/10/2012 57 Female 101 lb 1/13/2013 Consumer Jp
Primary
Secondary
Concomitant
Malaise Hospitalization 11/6/2012 59 Male 148 lb 1/14/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Other Serious 11/8/2012 63 Male 2/19/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Pruritus 12/6/2012 67 Female 2/19/2013 Other Health Professional Jp
Primary
Secondary
White Blood Cell Count Decreased Other Serious 8/24/2012 60 Male 150 lb 1/31/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Impairment Other Serious 3/13/2012 72 Male 152 lb 2/7/2013 Consumer Jp
Primary
Secondary
Concomitant
Skull Fractured Base Life Threatening 1/28/2013 48 Male 121 lb 2/14/2013 Consumer Jp
Primary
Secondary
Concomitant
Eczema Asteatotic 12/6/2012 67 Female 119 lb 2/26/2013 Consumer Jp
Primary
Secondary
Jaundice 11/9/2012 63 Male 154 lb 3/6/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Other Serious 3/19/2012 47 Male 141 lb 2/20/2013 Consumer Jp
Primary
Secondary
Concomitant
Toxic Skin Eruption Other Serious 4/27/2012 66 Male 139 lb 2/21/2013 Physician Jp
Primary
Secondary
Concomitant
Renal Failure Acute Other Serious 11/3/2012 57 Male 3/13/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Hyperuricaemia Hospitalization 2/14/2013 64 Male 3/29/2013 Other Health Professional Jp
Primary
Concomitant
Pneumonia Cytomegaloviral Hospitalization 9/29/2012 59 Male 117 lb 2/26/2013 Physician Jp
Primary
Secondary
Concomitant
Anaemia Other Serious 6/8/2012 57 Female 115 lb 2/25/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Hospitalization 12/11/2012 68 Male 128 lb 6/11/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Failure Acute Other Serious 11/5/2012 57 Male 143 lb 3/21/2013 Consumer Jp
Primary
Secondary
Concomitant
Renal Disorder Hospitalization 2/22/2012 66 Male 174 lb 1/25/2013 Consumer Jp
Primary
Secondary
Concomitant
Rash Hospitalization 2/26/2013 64 Male 3/29/2013 Other Health Professional Jp
Primary
Secondary
Concomitant
Urinary Tract Infection Hospitalization 2/9/2013 64 Male 3/14/2013 Other Health Professional Jp
Primary
Concomitant
Urinary Tract Infection Hospitalization 2/22/2013 64 Male 128 lb 3/22/2013 Consumer Jp
Primary
Secondary
Concomitant

Drug Data